Only for SerRS was there a small but significant increase in the size of oligomer (from 10 to ∼12.5 nm) and this only took place at high (100–150 μM) concentrations.
← all excerpts
Drug repurposing screens identify compounds that inhibit α-synuclein oligomers' membrane disruption and block antibody interactions.
1
—
—